Ang Nguyen

I follow the biotech industry closely and usually target developmental stage oncology treatments. Companies that seek to cure and treat disease garner most of my interest, as they have delivered tremendous returns for me.

I also keep an eye on developing trends and emerging markets that I believe show large upside growth potential. Commodities and new technologies make up the majority of my current investment portfolio.